Frequent loss of chromosome 12 in human epithelial ovarian tumors: A chromosomal In situ hybridization study

International Journal of Gynecological Pathology

Volumn 17, Issue 2, 1998, Pages 106-112

  Tanyi, János ^a,b   Tory, Kálmán ^a   Amo Takyi, Baffour Kwaku ^a   Füzesi, László ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Chromosomal in situ hybridization; Chromosome 12; Epithelial ovarian tumors

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER GENETICS; CHROMOSOME 12; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CLINICAL ARTICLE; DISOMY; DNA PROBE; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IN SITU HYBRIDIZATION; OVARY CANCER; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY;

EID: 0031898929     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199804000-00002     Document Type: Article

References (34)

1. Russel, P. Surface epithelial-stromal tumors of the ovary. In: Kurman RJ (ed). Blaustein's Pathology of the Female Genital Tract. New York: Springer-Verlag, 1994:705-82.
2. Pejovic T. Genetic changes in ovarian cancer. Ann Med 1995;27: 73-8.
3. Geurts van Kessel A, Suijkerbuijk RF, Sinke RJ, Looijenga L, Oosterhuis JW, de Jong B. Molecular cytogenetics of human germ cell tumours: i(12p) and related chromosomal anomalies. Eur Urol 1993;23:23-8.
4. Fletcher JA, Gibas Z, Donovan K, Perez-Atayde A, Genest D, Morton CC, Lage JM. Ovarian granulosa-stromal cell tumors are characterized by trisomy 12. Am J Pathol 1991;138:515-20.
5. Schofield DE, Fletcher JA. Trisomy 12 in pediatric granulosa-stromal cell tumors. Am J Pathol 1992;141:1265-9.
6. Bello MJ, Rey JA. Chromosome aberrations in metastatic ovarian cancer: relationship with abnormalities in primary tumors. Int J Cancer 1990;45:50-4.
7. Sreekantaiah C, Crickard K, Crickard U, Yoonessi M, Sandberg AA. Three related near-haploid clones in a primary endometrioid carcinoma of the ovary. Gynecol Oncol 1990;38:282-5.
8. Sato T, Saito H, Morita R, Koi S, Lee JH, Nakamura Y. Allelotype of human ovarian cancer. Cancer Res 1991;51:5118-22.
9. Zhu D, Ma MS, Zhao RZ, Li MY. Centromere spreading and centromeric aberrations in ovarian tumors. Cancer Genet Cytogenet 1995;80:63-5.
10. Jenkins RB, Bartelt D Jr, Stalboerger P, Persons D, Dahl RJ, Podratz K, Keeney G, Hartmann L. Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet Cytogenet 1993;71:76-86.
11. Thompson FH, Emerson J, Alberts D, et al. Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet Cytogenet 1994;73:33-45.
12. Pejovic T, Heim S, Mandahl N, et al. Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer 1992;4:58-68.
13. Yang-Feng TL, Li S, Han H, Schwartz PE. Frequent loss of heterozygosity on chromosome Xp and 13q in human ovarian cancer. Int J Cancer 1992;52:575-80.
14. Hopman AHN, Hooren van E, Kaa van de CA, Vooijs GP, Ramaekers FCS. Detection of numerical chromosomal aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers. Mod Pathol 1991;4:503-13.
15. Pejovic T, Heim S, Mandahl N, et al. Trisomy 12 is an consistent chromosomal aberration in benign ovarian tumors. Genes Chromosomes Cancer 1990;2:48-52.
16. Serov SF, Scully RE, Sobin LH. International histological classification and staging of tumors. No. 9. In: Histologic Typing of Ovarian Tumors. Geneva: World Health Organization, 1973.
17. Fleming KA, Evans M, Ryley KC, Franklin D, Lovell-Badge RH, Morey AL. Optimization of non-isotopic in situ hybridization of formalin-fixed, paraffin-embedded material using digoxigenin-labelled probes and transgenic tissues. J Pathol 1992;167:9-17.
18. Whawel SA, Wang Y, Fleming KA, Thompson EM, Thompson JN. Localization of plasminogen activator inhibitor-1 production in inflammed appendix by in situ mRNA hybridization. J Urol 1993;169:67-71.
19. Persons DL, Hartmann LC, Herath JF, Borell TJ, Cliby WA, Keeney GL, Jenkins RB. Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas. Am J Pathol 1993;142:733-41.
20. Lee W, Han K, Harris CP, Shim S, Kim S, Meisner LF. Use of FISH to detect chromosomal translocation and deletions. Am J Pathol 1993;143:15-9.
21. Miranda RN, Mark HFL, Medeiros LF. Fluorescent in situ hybridization in routinely processed bone marrow aspirate clot and core biopsy sections. Am J Pathol 1994;145:1309-14.
22. Hopman AHN, Ramaekers FCS, Raap AK. In situ hybridization as a tool to study numerical chromosome aberrations using in solid bladder tumors. Histochemistry 1988;8:307-16.
23. Kim SY, Lee JS, Ro JY, Gay ML, Hong WK, Hittelman WN. Interphase cytogenetics in paraffin sections of lung tumors by non-isoptopic in situ hybridization. Am J Pathol 1993;142:307-17.
24. Poddighe PJ, Ramaekers FCS, Hopman AHN. Interphase cytogenetics of tumours. J Pathol 1992;166:215-24.
25. Thompson CT, Leboit PE, Nederlof PM, Gray JW. Thick-section fluorescence in situ hybridization on formalin-fixed, paraffin-embedded archival tissue provides a histogenetic profile. Am J Pathol 1994:144:237-43.
26. Crabb ID, Hughes SS, Hicks DG, Puzas E, Tsao GJY, Rosier RN. Nonradioactive in situ hybridization using digoxigenin-labeled oligonucleotides. Am J Pathol 1992;141:579-89.
27. Suijkerbuijk RF, Looijenga L, de Jong B, Oosterhuis JW, Cassiman JJ, Geurts van Kessel A. Verification of isochromosome 12p and identification of other chromosome 12 aberrations in gonadal and extragonadal human germ cell tumors by bicolor double fluorescence in situ hybridization. Cancer Genet Cytogenet 1992;63: 8-16.
28. Brothman AR, Watson MJ, Zhu XL, Williams BJ, Rohr LR. Evaluation of 20 archival prostate tumor specimens by fluorescence in situ hybridization (FISH). Cancer Genet Cytogenet 1994; 75:40-4.
29. Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res 1995;55:1206-10.
30. Knight JC, Renwick PJ, Dal Cin P, van den Berghe H, Fletcher CDM. Translocation t(12;16)(q13′1) in myxoid liposarcoma and round cell liposarcoma: Molecular and cytogenetic analysis. Cancer Res 1995;55:24-7.
31. Fejzo MS, Yoon SJ, Montgomery KT, et al. Identification of a YAC spanning the translocation breakpoints in uterial leiomyomata, pulmonary chondroid hamartoma, and lipoma: physical mapping of the 12q14-q15 breakpoint region in uterine leiomyomata. Genomics 1995;26:265-71.
32. Kools PF, Wanschura S, Schoenmakers EF, et al. Identification of the chromosome 12 translocation breakpoint region of a pleiomorphic salivary gland adenoma with t(1;12)(p22;q15) as the sole cytogenetic abnormality. Cancer Gener Cytogenet 1995;79:1-7.
33. Ponce-Castaneda MV, Lee MH, Latres E, et al. p27Kip1: Chromosomal mapping to 12p12-12p13.1 and abscence of mutation in human tumors. Cancer Res 1995;55:1211-1214.
34. Berube NG, Speevak MD, Chevrette M. Suppression of tumorigenicity of human prostate cancer cell by introduction of human chromosome del(12)(q13). Cancer Res 1994;54:3077-81.